Calypte Only Company with Full Menu of Tests.
Seite 114 von 144 Neuester Beitrag: 03.03.11 19:06 | ||||
| Eröffnet am: | 08.04.05 22:44 | von: Brokersince1. | Anzahl Beiträge: | 4.592 |
| Neuester Beitrag: | 03.03.11 19:06 | von: schubby1 | Leser gesamt: | 251.096 |
| Forum: | Hot-Stocks | Leser heute: | 288 | |
| Bewertet mit: |  | |||
| Seite: < 1 | ... | 112 | 113 | | 115 | 116 | ... 144 > | ||||
LAKE OSWEGO, Ore., April 7 /PRNewswire-FirstCall/ -- Calypte Biomedical Corporation (Amex: HIV) (the "Company"), in compliance with American Stock Exchange Company Guide Section 610(b), today announced that the Company's independent registered public accounting firm included a going concern explanatory paragraph in its report on Calypte's consolidated financial statements as of and for the fiscal year ended December 31, 2005. The qualification was included as a result of the Company's recurring net losses and negative cash flows from operations. For information regarding management's plans in regard to these matters, please see the Calypte's Annual Report on Form 10-KSB filed with the Securities and Exchange Commission on March 31, 2006.
About Calypte Biomedical:
Calypte Biomedical Corporation is a U.S.-based healthcare company focused on the development and commercialization of diagnostic testing products for the detection of sexually transmitted diseases such as the HIV-1 BED Incidence EIA and new diagnostic test products for the rapid detection of HIV and other sexually transmitted diseases, several of which do not require blood samples. Calypte believes there is a significant need for rapid detection of such diseases globally to control their proliferation, particularly in developing countries, which lack the medical infrastructure to support laboratory-based testing. Calypte believes that testing for HIV and other sexually transmitted infectious diseases may make important contributions to public health, and could increase the likelihood of treating those with undetected HIV and other sexually transmitted diseases.
Statements in this press release that are not historical facts are forward-looking statements within the meaning of the Securities Act of 1933, as amended. Those statements include statements regarding the intent, belief or current expectations of the Company and its management. Such statements reflect management's current views, are based on certain assumptions and involve risks and uncertainties. Actual results, events, or performance may differ materially from the above forward-looking statements due to a number of important factors, and will be dependent upon a variety of factors, including, but not limited to, the Company's ability to obtain additional financing, if and as needed, and access funds from its existing financing arrangements that will allow it to continue its current and future operations and whether demand for its test products in domestic and international markets will generate sufficient revenues to achieve positive cash flow and profitability. The Company undertakes no obligation to publicly update these forward-looking statements to reflect events or circumstances that occur after the date hereof or to reflect any change in the Company's expectations with regard to these forward-looking statements or the occurrence of unanticipated events. Factors that may impact the Company's success are more fully disclosed in the Company's most recent public filings with the U.S. Securities and Exchange Commission ("SEC"), including its annual report on Form 10-KSB for the year ended December 31, 2005 and its subsequent filings with the SEC.
Company Contact:
Theodore R Gwin, Chief Financial Officer
(971) 204-0282
email: tgwin@calypte.com
Investor Relations Contact:
Tim Clemensen,
Rubenstein Investor Relations
Phone: (212) 843-9337
email: tclemensen@rubensteinir.com
SOURCE Calypte Biomedical Corporation
-0- 04/07/2006
/CONTACT: Theodore R Gwin, Chief Financial Officer of Calypte,
+1-971-204-0282, tgwin@calypte.com; or Investor Relations, Tim Clemensen of
Rubenstein Investor Relations, +1-212-843-9337, tclemensen@rubensteinir.com,
for Calypte /
/Web site: http://www.calypte.com /
(HIV)
CO: Calypte Biomedical Corporation
ST: Oregon
IN: BIO HEA IDC MTC
SU:
BR
-- NYF087 --
6814 04/07/200616:15 EDThttp://www.prnewswire.com
Bei 0,15$ steig ich wieder ein- und das wird bald sein ... Sorry für Euch.
Nur meine Meinung. keine Kauf- oder Verkaufsempfehlung.
Optionen
| Boardmail an "Kade_I" |
Wertpapier: Calypte Biomedical |
Thanks. China FDA approval process...
The Chinese SFDA approval process is very similar to U.S. FDA. Why? Because Chinese government has adopted many U.S. laws and regulations like many other development countries. If you apply new drugs in China, you may have to go through the same processes like here such as three phases and many years testing/waiting. Since Calypte HIV testing tool is not a drug so the process is much shorter.
First step: Calypte must go through Beijing Food/drug agency (Local agency) since Marr is registered in Beijing district. (All applicants must submit their applications to local province FDA agency first. Ex: if a company is located in ShangHai, the company must submit NDA to ShangHai FDA first).
Second step: if the Beijing (local) FDA agency approves the application, then they submit the files to SFDA on behalf of the applicant.. (the duty of local FDA agency is to ensure the application is complete, the company is genuine, the fee is paid, and other minor things. This will help SFDA to save manpower and time).
Third step: after receiving the package from local FDA. SFDA sends the application to CDE for evaluation. (CDE much likes U.S. FDA review panel; CDE...Center for drug Evaluation).
Forth step: CDE reviews and evaluates the application (here is Aware OMT). If CDE OKs (or not OKs) the application, the recommendatin will be made and the package will be send back to SFDA for approval (or disapproval).
Fifth step: SFDA takes final look and makes final decision (approval or disapproval) based on CDE recomm.
Sixth step: the package will be returned to Beijing (Local) FDA agency, and the applicant (here is Beijing Marr) picks up the package, signs on paper, receives certificate, and pays final fees if any.
I don't think Calypte mgmt fully understood the NDA process in China since the application was handled by Marr. When Beijing FDA agency accepted Marr/Calypte appl in Jan, CEO thought it was SFDA. Honest mistake.
Actually, the whole process is very simple and straight. SFDA approval time is much less than U.S. FDA's. The average of approval time for U.S. FDA is about 13 months. Chinese SFDA is about 100-180 days. However, if there is some problem/questions in the NDA, then the process may take many many months.
Anyways, it's guessing game now until.....
#2811. wie sieht es aus damit. immer noch keine antwort?
bitte keine ausflüchte und ausreden: ja oder nein
also, so stark kann dein glaube an caly ja nicht sein, aber da befindest du dich in bester gesellschaft. eigentlich kackt ja fast jeder (außer lucky-strike) der caly-jünger weg, wenn man ihn mal an seinem glauben festnageln will. das ist leider so meine erfahrung mit eurem völkchen...
also gut, ich modifiziere noch besser für dich.
mein sk muß exakt 0,23$ sein, nicht0,2279$ oder 0,2301$ nein, exakt 0,23$. dann gewinne ich.
deiner muß auf 0,26$ liegen oder drüber...
sollte sich der sk zwischen unseren tipps befinden, dann gewinnt natürlich keiner.
die wette gilt nur, wenn du bis 15.00h eingewilligt hast. eine flasche schampus: kein "mumm-pfurz-trocken" oder "freixenet", sondern normaler schampus (0,7l-flasche)(moet & chandon,Veuve Clicquot...etc...) kostet im supermarkt ca. 25,-.. --------------------------------------------------
--------------------------------------------------
2816. OK calyritter 07.04.06 15:21
OK !!!!!!!!!!!!!!!
quotemedia.com
0.23 100 NLS 15:59:43
0.22 20000 NLS 15:59:06
0.22 100 NLS 15:53:34
0.22 100 NLS 15:53:33
0.22 7000 NLS 15:52:49
0.22 12000 NLS 15:51:12
0.22 6200 NLS 15:51:12
0.22 10000 NLS 15:49:00
0.23 6600 NLS 15:44:40
0.22 100 NLS 15:33:39
0.22 31200 NLS 15:26:12
0.22 100 NLS 15:20:40
0.22 1000 NLS 15:07:31
0.22 100 NLS 15:04:55
0.22 100 NLS 14:47:10
freerealtime.com zeit ebenso 0,23$
Exchange QuoteLast Change (%) Trade Time Bid (size) Ask (size)
0.23 0 (0.00) 0 N/A N/A
alles weitere leite ich dir per bm zu.
Price Size Exch Time
0.21 9700 NLS 17:33:50
0.21 3800 NLS 17:33:50
0.21 1400 NLS 17:33:50
0.21 700 NLS 17:28:27
0.21 1000 NLS 17:02:42
0.21 2000 NLS 16:55:03
0.21 10000 NLS 16:54:52
0.21 61000 NLS 16:54:41
0.21 5000 NLS 16:54:41
0.21 10000 NLS 16:54:41
0.22 20000 NLS 16:23:48
0.22 3000 NLS 16:23:48
0.22 10000 NLS 16:23:18
0.22 8000 NLS 16:21:52
0.22 7000 NLS 16:21:52
0.23 100 NLS 15:59:43
0.22 20000 NLS 15:59:06
0.22 100 NLS 15:53:34
0.22 100 NLS 15:53:33
0.22 7000 NLS 15:52:49
0.22 12000 NLS 15:51:12
0.22 6200 NLS 15:51:12
0.22 10000 NLS 15:49:00
0.23 6600 NLS 15:44:40
0.22 100 NLS 15:33:39
0.22 31200 NLS 15:26:12
0.22 100 NLS 15:20:40
0.22 1000 NLS 15:07:31
0.22 100 NLS 15:04:55
0.22 100 NLS 14:47:10
Type Value Conf.
resist. 0.29 2
resist. 0.28 12
resist. 0.25 9
resist. 0.24 2
resist. 0.23 5
supp 0.22 9
supp 0.20 2
supp 0.20 20
supp 0.19 24
supp 0.18 2
supp 0.18 16
supp 0.17 16
supp 0.16 46
diese woche fallen die 0,20$...
oder sollte hier langsam einsicht einkehren, dass hier nur andere den rahm abschöpfen???
ich kann es nicht glauben.
calyritter, wo bist du eigentlich?
Support/Resistance
Type Value Conf.
resist. 0.29 2
resist. 0.28 12
resist. 0.25 9
resist. 0.24 2
resist. 0.23 4
resist. 0.22 9
resist. 0.21 2
supp 0.20 2
supp 0.20 16
supp 0.19 24
supp 0.18 2
supp 0.18 16
supp 0.17 16
supp 0.16 46
noch gut, um auszusteigen...
Price Size Exch Time
0.22 470100 AMX 18:27:17
0.21 7500 NLS 15:59:27
0.21 300 NLS 15:59:27
0.21 800 NLS 15:59:27
0.22 2000 AMX 15:58:59
0.22 4000 NLS 15:56:58
0.21 1000 NLS 15:54:54
0.21 10700 NLS 15:53:54
0.21 100 NLS 15:53:41
0.21 100 NLS 15:53:41
0.21 100 PAC 15:53:41
0.21 5000 NLS 15:47:39
0.21 5400 NLS 15:47:03
0.21 5000 NLS 15:42:54
0.21 5000 NLS 15:42:54
0.21 5000 NLS 15:34:21
0.22 400 AMX 15:04:24
0.21 1000 AMX 14:59:40
0.21 100 NLS 14:58:39
0.21 100 NLS 14:32:17
0.22 3000 NLS 14:08:06
0.22 1300 PAC 14:08:04
0.21 5000 NLS 14:06:10
0.21 100 AMX 14:02:32
0.21 1400 NLS 13:47:07
0.21 3000 NLS 13:46:16
0.21 7100 NLS 13:38:08
0.21 2000 NLS 13:38:08
0.21 900 NLS 13:38:08
0.21 2700 NLS 13:34:20
durchschnittshandelskurs: 0.2154$
aber da gibt es sicherlich noch so ein paar andere gestalten, die euch beschenken könnten...wenn ich mal soo in den bereich der fabeln und märchen abgleite....muhahahahahhaahhaha
aber klar, kein märchen ist schon schön, wie das, was man selbst erfindet ud woran man dann noch unerschütterlich glaubt, GALE???
du denkst doch auch, dass es okay ist, dass GALE für seine "gute arbeit" sogar noch einen bonus bekommt, oder?
muhahhahahahaha
Time & Sales most recent next page
Rec. Time Action Price Volume
10:31:20 AM Ask 0.21 36500
10:30:14 AM Trade 0.2 48000
10:26:56 AM Trade 0.201 100
10:18:30 AM Trade 0.2099 5000
10:18:30 AM Trade 0.2 5400
10:18:30 AM Trade 0.2 100
10:18:30 AM Trade 0.2 100
10:18:26 AM Trade 0.2 1900
10:18:22 AM Trade 0.2 1600
10:18:22 AM Trade 0.2 300
10:18:22 AM Trade 0.2 10000
10:18:18 AM Trade 0.2 5000
10:18:18 AM Trade 0.2011 5000
10:12:06 AM Trade 0.21 4900
10:10:28 AM Ask 0.21 27500
10:09:48 AM Ask 0.21 25000
10:09:48 AM Ask 0.21 13300
10:09:46 AM Ask 0.21 6300
10:09:46 AM Trade 0.21 1400
10:09:46 AM Trade 0.21 1400
Rec. Time Action Price Volume
10:31:20 AM Ask 0.21 36500
10:30:14 AM Trade 0.2 48000
10:26:56 AM Trade 0.201 100
10:18:30 AM Trade 0.2099 5000
10:18:30 AM Trade 0.2 5400
10:18:30 AM Trade 0.2 100
10:18:30 AM Trade 0.2 100
10:18:26 AM Trade 0.2 1900
10:18:22 AM Trade 0.2 1600
10:18:22 AM Trade 0.2 300
10:18:22 AM Trade 0.2 10000
10:18:18 AM Trade 0.2 5000
10:18:18 AM Trade 0.2011 5000
10:12:06 AM Trade 0.21 4900
10:10:28 AM Ask 0.21 27500
10:09:48 AM Ask 0.21 25000
10:09:48 AM Ask 0.21 13300
10:09:46 AM Ask 0.21 6300
10:09:46 AM Trade 0.21 1400
10:09:46 AM Trade 0.21 1400
wirklich GEIL denn ich sammel ab jetzt EIN !!!
Nicht zu jedem Preis aber jeden Tag eine kleine 5 Stellige - Stückzahl so negativ wie im Moment wieder könnte was kommen um denn Kurs zu Zünden ..... mal sehen was kommt.
Ich gehe volles Risiko - Wie immer - HOP oder TOP
( Bitte nicht kommentieren Joelu ... ich lege kein Wert drauf )
Time & Sales
Price Size Exch Time
0.201 2500 NLS 15:58:46
0.201 700 NLS 15:58:46
0.201 2900 NLS 15:58:10
0.201 100 NLS 15:53:17
0.201 100 NLS 15:53:11
0.20 3000 AMX 15:48:02
0.20 5600 NLS 15:41:31
0.20 300 NLS 15:41:31
0.20 3500 AMX 15:40:22
0.20 3500 AMX 15:39:20
0.21 10000 NLS 15:36:54
0.21 13000 NLS 15:36:54
0.20 10000 NSX 15:34:06
0.20 1200 NLS 15:30:15
0.20 4300 NLS 15:30:15
0.20 4300 NLS 15:30:15
0.21 300 NSX 15:09:39
0.20 100 NLS 15:05:46
0.21 100 PAC 14:54:51
0.21 100 PAC 14:54:49
0.21 100 PAC 14:54:49
0.21 100 PAC 14:54:49
0.21 100 PAC 14:54:49
0.21 400 PAC 14:54:49
0.21 2000 PAC 14:54:49
0.21 6000 NLS 14:54:24
0.21 8100 PAC 14:52:37
0.21 2000 PAC 14:52:37
0.21 3000 PAC 14:52:37
0.21 100 PAC 14:52:37
durchschnittshandelskurs: 0.2075$
Type Value Conf.
resist. 0.29 2
resist. 0.28 12
resist. 0.25 9
resist. 0.24 2
resist. 0.23 3
resist. 0.22 10
resist. 0.21 2
supp 0.20 2
supp 0.20 14
supp 0.19 36
supp 0.18 2
supp 0.18 16
supp 0.17 14
supp 0.16 46